These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15717631)

  • 41. Soluble endothelial protein C receptor: influence on arteriovenous fistula thrombosis development in hemodialysis patients.
    Bilgic A; Ozdemir FN; Bayraktar N; Karakus S; Sasak G; Arat Z; Sezer S; Haberal M
    Am J Nephrol; 2007; 27(4):366-72. PubMed ID: 17570903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
    Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
    Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.
    Chan MR; Young HN; Becker YT; Yevzlin AS
    Semin Dial; 2008; 21(3):274-9. PubMed ID: 18397205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura.
    Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B
    Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura.
    El-Bostany EA; El-Ghoroury EA; El-Ghafar EA
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):26-31. PubMed ID: 18180612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cephalic arch stenosis in patients with fistula access for hemodialysis: relationship to diabetes and thrombosis.
    Hammes M; Funaki B; Coe FL
    Hemodial Int; 2008 Jan; 12(1):85-9. PubMed ID: 18271847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vascular access outcomes in the elderly hemodialysis population: A USRDS study.
    Chan MR; Sanchez RJ; Young HN; Yevzlin AS
    Semin Dial; 2007; 20(6):606-10. PubMed ID: 17991212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [How to predict thrombosis of arteriovenous fistule?].
    Kapun S; Zibar L
    Acta Med Croatica; 2008 Feb; 62(1):9-13. PubMed ID: 18365494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of frequency of complications of arterio venous fistula in patients on dialysis: a two-year single center study from Iran.
    Derakhshanfar A; Gholyaf M; Niayesh A; Bahiraii S
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):872-5. PubMed ID: 19736495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anticardiolipin antibodies and early infarct of the myocardium].
    Gaeta G; Lupoli S; Brancaccio V; Effuso L; Russo V; Boccalatte A
    Cardiologia; 1998 Jul; 43(7):731-5. PubMed ID: 9738331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M
    Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular thrombosis associated with antiphospholipide syndrome.
    Glasnović M; Bosnjak I; Vcev A; Soldo I; Bedeković D; Milaković S; Hecimović V; Horvatić E; Bardek M
    Coll Antropol; 2008 Mar; 32(1):103-7. PubMed ID: 18494194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patency rate and complications of vascular access grafts for hemodialysis in lower extremities.
    Salimi J
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):929-32. PubMed ID: 18974578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
    García Cortés MJ; Viedma G; Sánchez Perales MC; Borrego FJ; Borrego J; Pérez del Barrio P; Gil Cunquero JM; Liébana A; Pérez Bañasco V
    Nefrologia; 2005; 25(3):307-14. PubMed ID: 16053012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticardiolipin antibody levels in women undergoing first in vitro fertilization/embryo transfer.
    Caccavo D; Pellegrino NM; Lorusso F; Capotorto M; Vacca M; Vimercati A; Depalo R
    Hum Reprod; 2007 Sep; 22(9):2494-500. PubMed ID: 17609246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Recurrence and prognosis in ischemic stroke patients with anticardiolipin antibody in Japan].
    Kitagawa Y; Shinohara Y; Niwa K; Yoshitoshi M; Kametsu Y
    Rinsho Shinkeigaku; 1994 Aug; 34(8):799-804. PubMed ID: 7994987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis.
    Opatrny L; David M; Kahn SR; Shrier I; Rey E
    J Rheumatol; 2006 Nov; 33(11):2214-21. PubMed ID: 17014001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.